Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism-related vascular thrombosis with microvascular injury and its consequences.
Zhao D, Han C, Mammadova-Bach E, Watanabe-Kusunoki K, Bandeira Honda TS, Li Y, Li C, Li Q, Long H, Lyubenov L, Shi C, Santovito D, Weber C, Boor P, Droste P, Parikh S, Shapiro J, De Chiara L, Carangelo G, Romagnani P, Klussmann S, Hoehlig K, Vater A, Anders HJ.
Zhao D, et al. Among authors: vater a.
Kidney Int. 2024 Aug 12:S0085-2538(24)00543-X. doi: 10.1016/j.kint.2024.07.020. Online ahead of print.
Kidney Int. 2024.
PMID: 39142565
Free article.